我们推荐在您的浏览器上开启Javascript，以获得最佳效果。

CD21 抗体

Name: CD21 抗体
SKU: ABIN967384
Availability: OutOfStock

CR2 适用: 小鼠 FACS, WB, IP, IHC (fro), BR 宿主: 大鼠 Monoclonal 7G6 unconjugated

Expression of CD21/CD35 on splenic B lymphocytes.

FACS

2 images

(18 references)

产品编号 ABIN967384

发货至: 中国

Datasheet as PDF

抗原 See all CD21 (CR2) 抗体

CD21 (CR2) (Complement Component (3d/Epstein Barr Virus) Receptor 2 (CR2))
适用
129

27

17

16

13

11

8

8

3

2

2

1
小鼠
宿主
83

69

1
大鼠
Compatible Secondaries
克隆类型
93

59

1
单克隆
标记
68

20

15

14

7

5

2

2

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1
This CD21 antibody is un-conjugated
应用范围
105

63

49

40

27

26

24

16

15

6

6

6

6

1

1

1
Flow Cytometry (FACS), Western Blotting (WB), Immunoprecipitation (IP), Immunohistochemistry (Frozen Sections) (IHC (fro)), Blocking Reagent (BR)

品牌

BD Pharmingen™

产品特性

1. Since applications vary, each investigator should titrate the reagent to obtain optimal results.
2. Please refer to us for technical protocols.
3. Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.
4. Sodium azide is a reversible inhibitor of oxidative metabolism, therefore, antibody preparations containing this preservative agent must not be used in cell cultures nor injected into animals. Sodium azide may be removed by washing stained cells or plate-bound antibody or dialyzing soluble antibody in sodium azide-free buffer. Since endotoxin may also affect the results of functional studies, we recommend the NA/LE (No Azide/Low Endotoxin) antibody format, if available, for in vitro and in vivo use.

纯化方法

The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.

免疫原

Purified Mouse CR1

克隆位点

7G6

亚型

IgG2b kappa

Top Product

Discover our top product CR2 Primary Antibody
anti-Complement Component (3d/Epstein Barr Virus) Receptor 2 (CR2) (AA 142-240) antibody
CR2 适用: 人 FACS, IHC, WB, ELISA, IF, StM, Coat 宿主: 小鼠 Monoclonal CR2-2754 unconjugated

anti-Complement Component (3d/Epstein Barr Virus) Receptor 2 (CR2) antibody
CR2 适用: 人 FACS, IHC, WB, ELISA, IF 宿主: 兔 Monoclonal 16F10 unconjugated Recombinant Antibody

anti-Complement Component (3d/Epstein Barr Virus) Receptor 2 (CR2) (AA 300-590) antibody
CR2 适用: 人 IHC, WB, IF 宿主: 兔 Polyclonal unconjugated

anti-Complement Component (3d/Epstein Barr Virus) Receptor 2 (CR2) (AA 740-964) antibody
CR2 适用: 人 FACS, WB, ELISA 宿主: 小鼠 Monoclonal 2D2H6 unconjugated

anti-Complement Component (3d/Epstein Barr Virus) Receptor 2 (CR2) (AA 981-1092) antibody
CR2 适用: 人, 大鼠 FACS, WB, ELISA, IHC (p) 宿主: 兔 Polyclonal unconjugated

anti-Complement Component (3d/Epstein Barr Virus) Receptor 2 (CR2) antibody
CR2 适用: 人, 小鼠, 大鼠 IHC, IF 宿主: 兔 Polyclonal unconjugated

anti-Complement Component (3d/Epstein Barr Virus) Receptor 2 (CR2) (AA 142-240) antibody
CR2 适用: 人 FACS, IHC, WB, IF, StM 宿主: 兔 Monoclonal CR2-3124R unconjugated Recombinant Antibody

anti-Complement Component (3d/Epstein Barr Virus) Receptor 2 (CR2) (AA 44-196) antibody
CR2 适用: 人 IHC, ELISA, StM, Coat 宿主: 小鼠 Monoclonal CR2-1952 unconjugated

anti-Complement Component (3d/Epstein Barr Virus) Receptor 2 (CR2) antibody
CR2 适用: 人, Pig, Cow, 犬 FACS, IHC (fro) 宿主: 小鼠 Monoclonal LT21 unconjugated

anti-Complement Component (3d/Epstein Barr Virus) Receptor 2 (CR2) antibody
CR2 适用: 人, 小鼠, 大鼠 IF, IHC (p) 宿主: 小鼠 Monoclonal 5F2 unconjugated

限制

仅限研究用
状态

Liquid

浓度

0.5 mg/mL

缓冲液

Aqueous buffered solution containing ≤0.09 % sodium azide.

储存液

Sodium azide

注意事项

This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

储存条件

4 °C

储存方法

Store undiluted at 4° C.
Cariappa, Tang, Parng, Nebelitskiy, Carroll, Georgopoulos, Pillai: "The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21." in: Immunity, Vol. 14, Issue 5, pp. 603-15, (2001) (PubMed).

Gommerman, Oh, Zhou, Tedder, Maurer, Galli, Carroll: "A role for CD21/CD35 and CD19 in responses to acute septic peritonitis: a potential mechanism for mast cell activation." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 165, Issue 12, pp. 6915-21, (2000) (PubMed).

Oliver, Martin, Kearney: "IgMhighCD21high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 162, Issue 12, pp. 7198-207, (1999) (PubMed).

Fischer, Goerg, Shen, Prodeus, Goodnow, Kelsoe, Carroll: "Dependence of germinal center B cells on expression of CD21/CD35 for survival." in: Science (New York, N.Y.), Vol. 280, Issue 5363, pp. 582-5, (1998) (PubMed).

Oliver, Martin, Gartland, Carter, Kearney: "Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses." in: European journal of immunology, Vol. 27, Issue 9, pp. 2366-74, (1997) (PubMed).

Hu, Martin, Weis, Weis: "Expression of the murine CD21 gene is regulated by promoter and intronic sequences." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 158, Issue 10, pp. 4758-68, (1997) (PubMed).

Axcrona, Gray, Leanderson: "Regulation of B cell growth and differentiation via CD21 and CD40." in: European journal of immunology, Vol. 26, Issue 9, pp. 2203-7, (1996) (PubMed).

Dempsey, Allison, Akkaraju, Goodnow, Fearon: "C3d of complement as a molecular adjuvant: bridging innate and acquired immunity." in: Science (New York, N.Y.), Vol. 271, Issue 5247, pp. 348-50, (1996) (PubMed).

Molina, Holers, Li, Fung, Mariathasan, Goellner, Strauss-Schoenberger, Karr, Chaplin: "Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 93, Issue 8, pp. 3357-61, (1996) (PubMed).

Ahearn, Fischer, Croix, Goerg, Ma, Xia, Zhou, Howard, Rothstein, Carroll: "Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen." in: Immunity, Vol. 4, Issue 3, pp. 251-62, (1996) (PubMed).

Tedder, Zhou, Engel: "The CD19/CD21 signal transduction complex of B lymphocytes." in: Immunology today, Vol. 15, Issue 9, pp. 437-42, (1994) (PubMed).

Martin, Weis: "Murine macrophages lack expression of the Cr2-145 (CR2) and Cr2-190 (CR1) gene products." in: European journal of immunology, Vol. 23, Issue 11, pp. 3037-42, (1993) (PubMed).

Yoshida, van den Berg, Dijkstra: "Two functionally different follicular dendritic cells in secondary lymphoid follicles of mouse spleen, as revealed by CR1/2 and FcR gamma II-mediated immune-complex trapping." in: Immunology, Vol. 80, Issue 1, pp. 34-9, (1993) (PubMed).

Kinoshita, Thyphronitis, Tsokos, Finkelman, Hong, Sakai, Inoue: "Characterization of murine complement receptor type 2 and its immunological cross-reactivity with type 1 receptor." in: International immunology, Vol. 2, Issue 7, pp. 651-9, (1991) (PubMed).

Thyphronitis, Kinoshita, Inoue, Schweinle, Tsokos, Metcalf, Finkelman, Balow: "Modulation of mouse complement receptors 1 and 2 suppresses antibody responses in vivo." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 147, Issue 1, pp. 224-30, (1991) (PubMed).

Wiersma, Kinoshita, Heyman: "Inhibition of immunological memory and T-independent humoral responses by monoclonal antibodies specific for murine complement receptors." in: European journal of immunology, Vol. 21, Issue 10, pp. 2501-6, (1991) (PubMed).

Heyman, Wiersma, Kinoshita: "In vivo inhibition of the antibody response by a complement receptor-specific monoclonal antibody." in: The Journal of experimental medicine, Vol. 172, Issue 2, pp. 665-8, (1990) (PubMed).

Kurtz, OToole, Christensen, Weis: "The murine complement receptor gene family. IV. Alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CR1." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 144, Issue 9, pp. 3581-91, (1990) (PubMed).
抗原

CD21 (CR2) (Complement Component (3d/Epstein Barr Virus) Receptor 2 (CR2))

别名

CD21/CD35 (CR2 产品)

别名

C3DR antibody, CD21 antibody, CR antibody, CVID7 antibody, SLEB9 antibody, Cd21 antibody, cd21 antibody, CR1 antibody, CR1-L antibody, CR2 antibody, complement C3d receptor 2 antibody, complement C3b/C4b receptor 1 (Knops blood group) antibody, CR2 antibody, Cr2 antibody, CR1 antibody

背景

The 7G6 antibody recognizes an epitope shared by 145-150-kDa and 190-kDa complement receptor proteins, originally designated CR2 (CD21) and CR1 (CD35), respectively. In the mouse, CD21 and CD35 are expressed on the majority of peripheral B lymphocytes, on the majority of resident peritoneal macrophages and mast cells, on peripheral blood granulocytes after treatment with N-formyl-Met-Leu-Phe, and on follicular dendritic cells, but not on thymocytes, T cells, erythrocytes, or platelets. CD21 is a ligand-binding component of the CD19/CD21/CD81 signal-transduction complex associated with the antigen receptor on B lymphocytes. CD21/CD35 also co-localizes with CD19 on the surface of peritoneal mast cells. Cr2null mice display impaired inflammatory and humoral immune responses in vivo. The 7G6 mAb has been reported to inhibit rosette formation by C3d-bearing sheep erythrocytes, to block the complement dependent trapping of immune complexes by follicular dendritic cells, and to down-regulate mouse CD21/CD35 expression upon in vivo application, thus inhibiting primary antibody responses to immunization. Co-stimulation of B-cell differentiation via Sepharose-coupled 7G6 antibody has also been observed. The 7G6 mAb recognizes an epitope on CD35 distinct from the epitope recognized by anti-mouse CD35, clone 8C12 (ABIN967625, for the purified antibody), and it does not block binding of 8C12 mAb to mouse CD35. This antibody is routinely tested by flow cytometric analysis.
Synonyms: CR2/CR1

途径

Complement System